No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not

• Josefine Beck-Friis ,

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Writing – original draft

  * E-mail: Josefine.Beck-Friis@gu.se

  Affiliation Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden

  https://orcid.org/0000-0003-2400-4092

  ⨯
• Susannah Leach,

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliations Department of Microbiology and Immunology, University of Gothenburg, Gothenburg, Sweden, Department of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden

  ⨯
• Elmir Omerovic,

  Roles Data curation, Formal analysis, Methodology, Supervision, Writing – review & editing

  Affiliations Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden

  ⨯
• Rickard Zeijlon,

  Roles Data curation, Writing – review & editing

  Affiliation Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden

  https://orcid.org/0000-0001-6422-604X

  ⨯
• Magnus Gisslen,

  Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing

  Affiliations Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden, Department of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden

  ⨯
• Aylin Yilmaz

  Roles Conceptualization, Supervision, Writing – review & editing

  Affiliation Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden

  ⨯